Swiss National Bank Buys 2,000 Shares of Masimo Corporation (MASI)
Swiss National Bank lifted its stake in Masimo Corporation (NASDAQ:MASI) by 2.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 79,800 shares of the medical equipment provider’s stock after purchasing an additional 2,000 shares during the quarter. Swiss National Bank owned about 0.15% of Masimo Corporation worth $7,276,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of MASI. Fortaleza Asset Management Inc. acquired a new stake in shares of Masimo Corporation in the second quarter valued at approximately $106,000. Neuburgh Advisers LLC increased its holdings in shares of Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 80 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after purchasing an additional 434 shares during the last quarter. Dubuque Bank & Trust Co. increased its holdings in shares of Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after purchasing an additional 61 shares during the last quarter. Finally, Bancorpsouth Inc. acquired a new stake in shares of Masimo Corporation in the first quarter valued at approximately $203,000. 83.26% of the stock is owned by hedge funds and other institutional investors.
Masimo Corporation (NASDAQ MASI) opened at 85.58 on Friday. The company has a 50-day moving average price of $86.35 and a 200 day moving average price of $91.07. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The stock has a market capitalization of $4.45 billion, a price-to-earnings ratio of 14.03 and a beta of 0.84.
Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. Masimo Corporation’s revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.57 EPS. Equities analysts predict that Masimo Corporation will post $2.80 earnings per share for the current year.
In other Masimo Corporation news, Director Sanford Fitch sold 14,000 shares of the business’s stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $92.06, for a total value of $1,288,840.00. Following the completion of the transaction, the director now directly owns 90,249 shares in the company, valued at approximately $8,308,322.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Anand Sampath sold 40,000 shares of the business’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the completion of the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at $1,840,000. The disclosure for this sale can be found here. Insiders sold a total of 126,000 shares of company stock valued at $11,732,930 over the last quarter. 16.60% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Swiss National Bank Buys 2,000 Shares of Masimo Corporation (MASI)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/16/swiss-national-bank-buys-2000-shares-of-masimo-corporation-masi.html.
Several equities research analysts recently commented on the company. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Monday, August 14th. BidaskClub cut Masimo Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price target (up previously from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. Roth Capital increased their price target on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Finally, Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $95.00.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.